SEARCH RESULTS FOR: "Tag: exel"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(3)
2017(2)
2016(3)
2015(1)
CATEGORIES
Analyst Update(1)
Buzz Stocks(4)
Intraday Option Activity(2)
Midday Market Check(1)
Opening View(1)
Quantitative Analysis(3)
Stock Market News(2)
Stocks On the Move(2)
Technical Analysis(2)

3/18/2019 1:06 PM
Exelixis, Inc. (NASDAQ:EXEL) shares are fresh off a new high, thanks to some upbeat analyst attention. Specifically, Morgan Stanley upgraded the biotech stock to "equal weight" from "underweight," and...
2/13/2019 10:29 AM
The shares of Exelixis Inc. (NASDAQ:EXEL) shot higher out of the gate this morning, but were last seen down 0.7% at $21.53, even though the company reported fourth-quarter earnings and revenue that ...
5/10/2018 10:19 AM
Exelixis, Inc. (NASDAQ:EXEL) stock is down 11.8% to trade at $19.13 this morning, after the biotech company's colorectal cancer drug that was tested in combination with Roche's Tecentriq failed late-...
2/23/2018 1:18 PM
ImmunoGen, Inc. (NASDAQ:IMGN) shares have been on a tear in 2018, advancing more than 75% already this year. What's more, IMGN stock could have room to run, if recent history is any indicator. Meanwhi...
1/19/2018 2:48 PM
The shares of biotech Exelixis, Inc. (NASDAQ:EXEL) -- which makes Cabometyx -- have been in a channel of higher highs and lows since early 2016, gaining 55% over the past year. Since its most recent...
 
Special Offers from Schaeffer's Trading Partners